Literature DB >> 26360234

Women's Attitudes Toward Cervicovaginal Self-Sampling for High-Risk HPV Infection on the US-Mexico Border.

Eribeth Penaranda1, Jennifer Molokwu, Silvia Flores, Theresa Byrd, Louis Brown, Navkiran Shokar.   

Abstract

OBJECTIVE: The purpose of this study was to assess the acceptability and intention to use cervicovaginal self-sampling for high-risk human papillomavirus infection after receiving an educational intervention among the predominantly Hispanic population residing along the US-Mexico border.
METHODS: Women received an educational intervention about cervical cancer prevention through screening with conventional cytology and with self-sampling for high-risk human papillomavirus. After the educational intervention, women performed the self-sampling test. Women's attitudes toward the self-sampling test and cervical cytology were assessed and compared.
RESULTS: A total of 110 women aged 30 to 65 years completed the study. The mean (SD) age of the population was 48 (9.3) years. Most (87%) self-identified as being Hispanic and half were born in Mexico; 16% had not had cervical cytology done in 3 years. Self-sampling was more acceptable than cervical cytology; mean (SD) acceptability scores were 25.0 (2.9) and 22.7 (3.0), respectively, with the maximum possible score being 28 (p < .001). A large proportion (42.7%) of women preferred both tests equally. We found high intention to use and recommend self-sampling. Contrary to previous studies, there were no differences between cervical cytology and self-sampling regarding women's concerns about performing the test well and the accuracy of the test, which we attribute to the educational intervention.
CONCLUSION: The high acceptability of self-sampling after participants received education about the test and the reported intention to use it if made available add to the evidence on the feasibility of integrating self-testing within cervical cancer screening guidelines.

Entities:  

Mesh:

Year:  2015        PMID: 26360234      PMCID: PMC4583792          DOI: 10.1097/LGT.0000000000000134

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  30 in total

Review 1.  Human papillomavirus testing in the prevention of cervical cancer.

Authors:  Mark Schiffman; Nicolas Wentzensen; Sholom Wacholder; Walter Kinney; Julia C Gage; Philip E Castle
Journal:  J Natl Cancer Inst       Date:  2011-01-31       Impact factor: 13.506

2.  Comparative community outreach to increase cervical cancer screening in the Mississippi Delta.

Authors:  Philip E Castle; Alfio Rausa; Tameka Walls; Patti E Gravitt; Edward E Partridge; Vanessa Olivo; Shelley Niwa; Kerry Grace Morrissey; Laura Tucker; Hormuzd Katki; Isabel Scarinci
Journal:  Prev Med       Date:  2011-04-08       Impact factor: 4.018

3.  Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program.

Authors:  Murat Gök; Folkert J van Kemenade; Daniëlle A M Heideman; Johannes Berkhof; Lawrence Rozendaal; Johan W M Spruyt; Jeroen A M Beliën; Milena Babovic; Peter J F Snijders; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2011-05-30       Impact factor: 7.396

4.  Acceptability of self-collected human papillomavirus specimens as a primary screen for cervical cancer.

Authors:  B L Quincy; D J Turbow; L N Dabinett
Journal:  J Obstet Gynaecol       Date:  2012-01       Impact factor: 1.246

5.  Heterogeneity in breast and cervical cancer screening practices among female Hispanic immigrants in the United States.

Authors:  Catalina Lawsin; Deborah Erwin; Zoran Bursac; Lina Jandorf
Journal:  J Immigr Minor Health       Date:  2011-10

6.  Breast and cervical cancer screening utilization among Hispanic women living near the United States-Mexico border.

Authors:  Tomas Nuño; Philip E Castle; Robin Harris; Antonio Estrada; Francisco García
Journal:  J Womens Health (Larchmt)       Date:  2011-03-23       Impact factor: 2.681

7.  Self-sampling for human papillomavirus in a community setting: feasibility in Hispanic women.

Authors:  Israel De Alba; Hoda Anton-Culver; F Allan Hubbell; Argyrios Ziogas; James R Hess; America Bracho; Caleb Arias; Alberto Manetta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

8.  Self-sampling experiences among non-attendees to cervical screening.

Authors:  Anni Virtanen; Pekka Nieminen; Meri Niironen; Tapio Luostarinen; Ahti Anttila
Journal:  Gynecol Oncol       Date:  2014-10-02       Impact factor: 5.482

9.  Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study.

Authors:  I Wikström; M Lindell; K Sanner; E Wilander
Journal:  Br J Cancer       Date:  2011-07-05       Impact factor: 7.640

10.  HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.

Authors:  A Szarewski; L Cadman; D Mesher; J Austin; L Ashdown-Barr; R Edwards; D Lyons; J Walker; J Christison; A Frater; J Waller
Journal:  Br J Cancer       Date:  2011-02-22       Impact factor: 7.640

View more
  9 in total

Review 1.  Acceptability, Feasibility and Uptake of HPV Self-Sampling Among Immigrant Minority Women: a Focused Literature Review.

Authors:  Sarah Marshall; Mandana Vahabi; Aisha Lofters
Journal:  J Immigr Minor Health       Date:  2019-12

Review 2.  Variation in Cervical Cancer Screening Preferences among Medically Underserved Individuals in the United States: A Systematic Review.

Authors:  Caitlin B Biddell; Meghan C O'Leary; Stephanie B Wheeler; Lisa P Spees
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-26       Impact factor: 4.254

3.  Assessing Acceptability of Self-Sampling Kits, Prevalence, and Risk Factors for Human Papillomavirus Infection in American Indian Women.

Authors:  Rachel L Winer; Angela A Gonzales; Carolyn J Noonan; Stephen L Cherne; Dedra S Buchwald
Journal:  J Community Health       Date:  2016-10

4.  Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women.

Authors:  Mahirah Ma'som; Nirmala Bhoo-Pathy; Nazrila Hairizan Nasir; Jerome Bellinson; Shridevi Subramaniam; Yuntong Ma; Siew-Hwei Yap; Pik-Pin Goh; Patti Gravitt; Yin Ling Woo
Journal:  BMJ Open       Date:  2016-08-04       Impact factor: 2.692

5.  Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.

Authors:  Betania Allen-Leigh; Patricia Uribe-Zúñiga; Leith León-Maldonado; Brandon J Brown; Attila Lörincz; Jorge Salmeron; Eduardo Lazcano-Ponce
Journal:  BMC Cancer       Date:  2017-11-09       Impact factor: 4.430

6.  Self-sampling to improve cervical cancer screening coverage in Switzerland: a randomised controlled trial.

Authors:  Manuela Viviano; Rosa Catarino; Emilien Jeannot; Michel Boulvain; Manuela Undurraga Malinverno; Pierre Vassilakos; Patrick Petignat
Journal:  Br J Cancer       Date:  2017-04-20       Impact factor: 7.640

Review 7.  The acceptability of vaginal smear self-collection for screening for cervical cancer: a systematic review.

Authors:  Natalia Serrano Doratioto Faria Braz; Noely Paula Cristina Lorenzi; Isabel Cristina Esposito Sorpreso; Lana Maria de Aguiar; Edmund Chada Baracat; José Maria Soares-Júnior
Journal:  Clinics (Sao Paulo)       Date:  2017-03       Impact factor: 2.365

8.  Acceptability of Human Papillomavirus Self-Sampling for Cervical Cancer Screening in an Indigenous Community in Guatemala.

Authors:  Anna Gottschlich; Alvaro Rivera-Andrade; Edwin Grajeda; Christian Alvarez; Carlos Mendoza Montano; Rafael Meza
Journal:  J Glob Oncol       Date:  2017-01-18

9.  HPV self-sampling in the follow-up of women after treatment of cervical intra-epithelial neoplasia: A prospective study in a high-income country.

Authors:  Manuela Viviano; Pierre Vassilakos; Ulrike Meyer-Hamme; Lorraine Grangier; Shahzia Lambat Emery; Manuela Undurraga Malinverno; Patrick Petignat
Journal:  Prev Med Rep       Date:  2021-09-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.